These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 28202356)

  • 1. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.
    Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ
    J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of Patients with Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    Lai HH; Thu JHL; Moh FV; Paradis A; Vetter J
    J Urol; 2019 Sep; 202(3):546-551. PubMed ID: 30916629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
    Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
    J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthetic Bladder Capacity is a Clinical Biomarker for Interstitial Cystitis/Bladder Pain Syndrome Subtypes.
    Plair A; Evans RJ; Langefeld CD; Matthews CA; Badlani G; Walker SJ
    Urology; 2021 Dec; 158():74-80. PubMed ID: 34303757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Tripp DA;
    J Urol; 2015 Jan; 193(1):138-44. PubMed ID: 25092637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome.
    Colaco M; Koslov DS; Keys T; Evans RJ; Badlani GH; Andersson KE; Walker SJ
    J Urol; 2014 Oct; 192(4):1123-9. PubMed ID: 24840534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history.
    Seth A; Teichman JM
    J Urol; 2008 Nov; 180(5):2029-33. PubMed ID: 18804240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study.
    Chancellor MB; Bartolone SN; Veerecke A; Lamb LE
    J Urol; 2018 May; 199(5):1344-1350. PubMed ID: 29225061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of Pelvic Pain, Urgency, and Frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome.
    Brewer ME; White WM; Klein FA; Klein LM; Waters WB
    Urology; 2007 Oct; 70(4):646-9. PubMed ID: 17707887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome.
    Schachar JS; Evans RJ; Parks GE; Zambon J; Badlani G; Walker SJ
    Int Urogynecol J; 2019 Nov; 30(11):1863-1870. PubMed ID: 31254048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome.
    Kirk PS; Santiago-Lastra Y; Qin Y; Stoffel JT; Clemens JQ; Cameron AP
    Neurourol Urodyn; 2018 Aug; 37(6):2002-2007. PubMed ID: 29566264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices.
    Huang MC; Hsieh CH; Chang WC; Chang ST; Lee MS
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):718-721. PubMed ID: 30342658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic response during bladder hydrodistention reflects the severity of symptoms in patients with bladder pain syndrome/interstitial cystitis.
    Kim SW; Son HS; Troya IS; Kim JY; Kim MJ; Fraser MO; Kim JH
    Neurourol Urodyn; 2017 Mar; 36(3):677-682. PubMed ID: 27028369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.
    Nickel JC; Shoskes D; Irvine-Bird K
    J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Relevance of Bladder Histopathological Findings and Their Impact on Treatment Outcomes among Patients with Interstitial Cystitis/Bladder Pain Syndrome: An Investigation of the European Society for the Study of Interstitial Cystitis Histopathological Classification.
    Jhang JF; Hsu YH; Jiang YH; Ho HC; Kuo HC
    J Urol; 2021 Jan; 205(1):226-235. PubMed ID: 32856961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of self-reported nocturia in patients with interstitial cystitis, and effects of bladder hydrodistention (with fulguration of Hunner lesions) on nocturia.
    Otsuka A; Suzuki T; Aki R; Matsushita Y; Tamura K; Motoyama D; Ito T; Sugiyama T; Miyake H
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O141-O146. PubMed ID: 30010251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.
    Nickel JC; Tripp DA; Pontari M; Moldwin R; Mayer R; Carr LK; Doggweiler R; Yang CC; Mishra N; Nordling J
    J Urol; 2010 Oct; 184(4):1358-63. PubMed ID: 20719340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.